Blood Glucose System Maker Asks High Court To Decide Who Institutes Inter Partes Review
WASHINGTON, D.C. — A manufacturer of a blood glucose monitoring system on Sept. 20 petitioned the U.S. Supreme Court to decide whether the Leahy-Smith America Invents Act (AIA) permits the Patent...To view the full article, register now.
Already a subscriber? Click here to view full article